Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

8415.      Gawoski JM, Ooi WW.  Dengue fever mimicking plasma cell leukemia. Arch Pathol Lab Med. 2003 Aug;127(8):1026-7.

8416.      Gokhale MD, Barde PV, Sapkal GN, Gore MM, Mourya DT. Vertical transmission of Dengue-2 virus through Aedes albopictus mosquitoes. J Commun Dis 2001; 33(3): 212-15.

8417.      Watanaveeradej V, Endy TP, Samakoses R, Kerdpanich A, Simasathien S, Polprasert N, Aree C, Vaughn DW, Ho C, Nisalak A. Transplacentally transferred maternal-infant antibodies to dengue virus. Am J Trop Med Hyg. 2003 Aug;69(2):123-8.  

Pathogenesis:

8418.      Hanley KA, Manlucu LR, Gilmore LE, Blaney JE Jr, Hanson CT, Murphy BR, Whitehead SS. A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4. Virology. 2003 Jul 20;312(1):222-32.

8419.      Huang YH, Lei HY, Liu HS, Lin YS, Chen SH, Liu CC, Yeh TM. Tissue plasminogen activator induced by dengue virus infection of human endothelial cells. J Med Virol. 2003 Aug;70(4):610-6.

8420.    Hwang KP, Chu PY, Tung YC, Wang HL, Yueh YY, Wu YC, Chin C, Lin KH.  Molecular epidemiological study of dengue virus type 1 in Taiwan. J Med Virol. 2003 Jul;70(3):404-9.

8421.      Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, Sawasdivorn S, Duangchinda T, Dong T, Rowland-Jones S, Yenchitsomanus PT, McMichael A, Malasit P, Screaton G.  Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med. 2003 Jul;9(7):921-7.

8422.      Roberts MG, Heesterbeek JA.  A new method for estimating the effort required to control an infectious disease. Proc R Soc Lond B Biol Sci. 2003 Jul 7;270(1522):1359-64.

8423.      Shafee N, AbuBakar S. Dengue virus type 2 NS3 protease and NS2B-NS3 protease precursor induce apoptosis. J Gen Virol. 2003 Aug;84(Pt 8):2191-5.

8424.      Welsh RM, Rothman AL. Dengue immune response: low affinity, high febrility. Nat Med. 2003 Jul;9(7):820-2.  

Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

9038.  John Victor T, Malathi M, Guruswamy D, Desai A, Anuradha L, Rani C, Krishnamurthy P ():   Dengue fever outbreaks in two villages of Dharmapuri district in Tamil nadu.  Indian J Med Res 2002; 116(Oct): 133-9.

9039.  Lupi O, Tyring SK. Tropical dermatology: viral tropical diseases. J Am Acad Dermatol. 2003 Dec;49(6):979-1000; quiz 1000-2. Review.

9040.  Oishi K, Inoue S, Cinco MT, Dimaano EM, Alera MT, Alfon JA, Abanes F, Cruz DJ, Matias RR, Matsuura H, Hasebe F, Tanimura S, Kumatori A, Morita K, Natividad FF, Nagatake T. Correlation between increased platelet-associated IgG and thrombocytopenia in secondary dengue virus infections. J Med Virol. 2003 Oct;71(2):259-64.

Pathogenesis:

9041.  Catteau A, Kalinina O, Wagner MC, Deubel V, Courageot MP, Despres P. Dengue virus M protein contains a proapoptotic sequence referred to as ApoptoM. J Gen Virol. 2003 Oct;84(Pt 10):2781-93.

9042.  Gubler DJ. Aedes albopictus in Africa. Lancet Infect Dis. 2003 Dec;3(12):751-2.

9043.  Just-Nubling G, Korn S, Ludwig B, Stephan C, Doerr HW, Preiser W. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects. Infection. 2003 Oct;31(5):318-23.

9044.  Lo Re V 3rd, Gluckman SJ. Fever in the returned traveler. Am Fam Physician. 2003 Oct 1;68(7):1343-50. Review.

9045.  Raviprakash K, Ewing D, Simmons M, Porter KR, Jones TR, Hayes CG, Stout R, Murphy GS. Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys. Virology. 2003 Oct 25;315(2):345-52.

9046.  Warke RV, Xhaja K, Martin KJ, Fournier MF, Shaw SK, Brizuela N, De Bosch N, Lapointe D, Ennis FA, Rothman AL, Bosch I. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol. 2003 Nov;77(21):11822-32.

9047.  Wei HY, Jiang LF, Fang DY, Guo HY. Dengue virus type 2 infects human endothelial cells through binding of the viral envelope glycoprotein to cell surface polypeptides. J Gen Virol. 2003 Nov;84(Pt 11):3095-8.

Vaccines:

9048.  Jaiswal S, Khanna N, Swaminathan S. Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2. J Virol. 2003 Dec;77(23):12907-13.

9049.  Raviprakash K, Ewing D, Simmons M, Porter KR, Jones TR, Hayes CG, Stout R, Murphy GS. Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys. Virology. 2003 Oct 25;315(2):345-52.

Therapy:

9050.  Sharma DC.  Delays hinder outbreak investigations in India. Lancet Infect Dis. 2003 Oct;3(10):607.

9051. Huang CY, Butrapet S, Tsuchiya KR, Bhamarapravati N, Gubler DJ, Kinney RM.  Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development. J Virol. 2003 Nov;77(21):11436-47.

Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

9667.   Chincholkar SV, Kulkarni AT. Problems and prospects of dengue haemorrhagic fever. Indian med Gaz 2003; 137(2): 56-8.

9668.   Koraka P, Murgue B, Deparis X, Van Gorp EC, Setiati TE, Osterhaus AD, Groen J.  Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity. J Med Virol. 2004 Mar;72(3):445-50.

9669.   Mangada MM, Ennis FA, Rothman AL. Quantitation of dengue virus specific CD4+ T cells by intracellular cytokine staining. J Immunol Methods. 2004 Jan;284(1-2):89-97.

9670.   Wong SJ, Demarest VL, Boyle RH, Wang T, Ledizet M, Kar K, Kramer LD, Fikrig E, Koski RA. Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay. J Clin Microbiol. 2004 Jan;42(1):65-72.

Pathogenesis:

9671.   Huber K, Loan LL, Chantha N, Failloux AB. Human transportation influences Aedes aegypti gene flow in Southeast Asia. Acta Trop. 2004 Mar;90(1):23-9.

9672.  Lin YS, Lin CF, Lei HY, Liu HS, Yeh TM, Chen SH, Liu CC. Antibody-mediated endothelial cell damage via nitric oxide. Curr Pharm Des. 2004;10(2):213-21. Review.

9673.  Mantke OD, Lemmer K, Biel SS, Groen J, Schmitz H, Durand JP, Zeller H, Niedrig M. Quality control assessment for the serological diagnosis of dengue virus infections. J Clin Virol. 2004 Feb;29(2):105-12.

9674.  Peyerl-Hoffmann G, Schwobel B, Jordan S, Vamisaveth V, Phetsouvanh R, Christophel EM, Phompida S, Sonnenburg FV, Jelinek T. Serological investigation of the prevalence of anti-dengue IgM and IgG antibodies in Attapeu Province, South Laos. Clin Microbiol Infect. 2004 Feb;10(2):181-4.

9675.   Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR, Harris E. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol. 2004 Mar;78(6):2701-10.

9676.  Thongtan T, Panyim S, Smith DR. Apoptosis in dengue virus infected liver cell lines HepG2 and Hep3B. J Med Virol. 2004 Mar;72(3):436-44.

Vaccines:

9677.   Deen JL. Editorial: the challenge of dengue vaccine development and introduction. Trop Med Int Health. 2004 Jan;9(1):1-3.

9678.   Sabchareon A, Lang J, Chanthavanich P, Yoksan S, Forrat R, Attanath P, Sirivichayakul C, Pengsaa K, Pojjaroen-Anant C, Chambonneau L, Saluzzo JF, Bhamarapravati N.   Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children. Pediatr Infect Dis J. 2004 Feb;23(2):99-109.

Therapy:

9679.   Alam R, Siddiqui FM, Rahman S, Haque AK, Sarker CB, Siddiqui NI, Das SN, Kahhar A, Zafar SA, Khandaker AK, Ahmed T, Haque MF. Management of dengue by the WHO guided national guidelines. Mymensingh Med J. 2004 Jan;13(1):43-7.

Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

10353.  Balasubramanian S, Anandnathan K, Shivbalan S, Datta M, Amalraj E. Cut-off  ematocrit value for hemoconcentration in dengue hemorrhagic fever. J Trop Pediatr. 2004 Apr;50(2):123-4.

10354.  Jessie K, Fong MY, Devi S, Lam SK, Wong KT. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis. 2004 Apr 15;189(8):1411-8.

Pathogenesis:

10355.  Ashburn PM, Craig CF; US Army Board for the Study of Tropical Diseases. Experimental investigations regarding the etiology of dengue fever. 1907. J Infect Dis. 2004 May 1;189(9):1747-83; discussion 1744-6.

10356.  Das P. Infectious disease surveillance update. Lancet Infect Dis. 2004 May;4(5):259.

10357.  Liew KJ, Chow VT. Differential display RT-PCR analysis of ECV304 endothelial-like cells infected with dengue virus type 2 reveals messenger RNA expression profiles of multiple human genes involved in known and novel roles. J Med Virol. 2004 Apr;72(4):597-609.

Vaccines:

10358.  Rothman AL. Dengue: defining protective versus pathologic immunity. J Clin Invest. 2004 Apr;113(7):946-51. Review.

10359.  Wu JJ, Huang DB, Pang KR, Tyring SK. Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations. J Am Acad Dermatol. 2004 Apr;50(4):495-528; quiz 529-32. Review.

Therapy:

10360.  Men R, Yamashiro T, Goncalvez AP, Wernly C, Schofield DJ, Emerson SU, Purcell RH, Lai CJ.  Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus. J Virol. 2004 May;78(9):4665-74.

10361.  O'Hanlon LH. Tinkering with genes to fight insect-borne disease. Researchers create genetically modified bugs to fight malaria, Chagas, and other diseases. Lancet. 2004 Apr 17;363(9417):1288-9.